Boehringer Ingelheim announces new data from hepatitis C virus portfolio
Boehringer Ingelheim announced today that new data from its hepatitis C virus portfolio will be presented in scientific sessions at The Liver Meeting® 2011, the 62 nd Annual Meeting of the American Association for the Study of Liver Diseases, taking place November 4 - November 8 in San Francisco, CA.
Over 1,000 new cases of Hepatitis-C are diagnosed in Finland annually.